Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 51 | 0 | 0 | 0 | €393.40 | €456.30 | 15.988% |
| Neurocrine Bioscience | 49 | 0 | 2 | 0 | €133.55 | €148.09 | 10.889% |
| Insulet Corp. | 47 | 0 | 15 | 0 | €261.60 | €315.97 | 20.784% |
| Ionis Pharmaceuticals Inc. | 48 | 1 | 2 | 0 | €70.26 | €71.43 | 1.664% |
| Exelixis Inc. | 40 | 0 | 0 | 0 | €38.09 | €40.48 | 6.268% |
| Jazz Pharmaceuticals plc | 39 | 0 | 4 | 0 | €145.80 | €170.70 | 17.075% |
| Merit Medical Systems | 31 | 0 | 2 | 0 | €71.00 | €95.59 | 34.635% |
| PTC Therapeutics Inc. | 32 | 2 | 0 | 0 | €65.50 | €69.08 | 5.469% |
| Acadia Pharmaceuticals | 27 | 1 | 2 | 0 | €23.57 | €27.38 | 16.161% |
| United Therapeutics | 24 | 1 | 0 | 0 | €415.90 | €480.20 | 15.460% |
| Icon plc | 21 | 0 | 0 | 0 | €159.60 | €203.65 | 27.599% |
| Ultragenyx Pharmaceutical Inc. | 21 | 0 | 1 | 0 | €31.20 | €78.31 | 150.990% |
| Arrowhead Pharmaceuticals Inc. | 19 | 0 | 6 | 0 | €52.76 | €64.41 | 22.087% |
| Halozyme Therapeutics Inc. | 21 | 2 | 3 | 1 | €54.40 | €67.75 | 24.541% |
| Masimo Corp. | 17 | 0 | 2 | 0 | €121.70 | €174.29 | 43.213% |
| Bio-Techne Corp. | 17 | 0 | 1 | 0 | €53.00 | €60.82 | 14.760% |
| Alkermes plc | 17 | 0 | 4 | 0 | €25.00 | €38.70 | 54.809% |
| Repligen Corp. | 18 | 1 | 0 | 0 | €141.70 | €156.77 | 10.636% |
| Bruker Corp. | 15 | 0 | 1 | 0 | €41.24 | €45.57 | 10.487% |
| LivaNova plc | 15 | 0 | 2 | 0 | €54.50 | €57.19 | 4.939% |
| Xencor Inc. | 15 | 2 | 1 | 0 | €15.30 | €22.87 | 49.490% |
| Nektar Therapeutics | 14 | 2 | 1 | 1 | €0.58 | €6.37 | 992.790% |
| Agios Pharmaceuticals Inc. | 10 | 1 | 5 | 0 | €24.00 | €43.63 | 81.773% |
| Ensign Group Inc. | 9 | 0 | 1 | 0 | €153.00 | €159.91 | 4.515% |
| Omnicell Inc. | 8 | 0 | 0 | 0 | €34.40 | €35.26 | 2.500% |